DI BELLA METHOD
>
DOCUMENTATION INDEX > MDB - Documents
Effects of vasoactive intestinal peptide (VIP) and somatostatin (SST) on lipoprotein receptor expression by A431 tumor cells.
(30/05/2003)
Detail
Antitumor and antiangiogenic effects of somatostatin receptor-targeted in situ radiation with (111)In-DTPA-JIC 2DL.
(30/05/2003)
Detail
Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.
(30/05/2003)
Detail
Two familial giant pituitary adenomas associated with overweight: clinical, morphological and genetic features.
(30/05/2003)
Detail
Distribution and functional significance of somatostatin receptors in malignant melanoma.
(30/05/2003)
Detail
Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid.
(30/05/2003)
Detail
Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patient.
(30/05/2003)
Detail
Somatostatinergic control of Kaposi's sarcoma growth through the inhibition of angiogenesis]
(30/05/2003)
Detail
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
(30/05/2003)
Detail
Clinical correlates in acromegalic patients with pituitary tumors expressing GSP oncogenes.
(30/05/2003)
Detail
Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy.
(30/05/2003)
Detail
Dosimetric comparison of radionuclides for therapy of somatostatin receptor-expressing tumors.
(30/05/2003)
Detail
Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery.
(30/05/2003)
Detail